Lung Infection clinical trials

Explore recruiting lung infection clinical trials.

Recruiting lung infection studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Lung Infection trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Adding oxygen to enhance antibiotic treatment of chronic lung infection

Denmark

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Phase III, Multicentre, Randomised, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Tozorakimab (MEDI3506) in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen (TILIA)

France, Sweden, Bulgaria, Romania, Greece, Italy +8 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Nebulized Bacteriophage Treatment in Outpatient Adult Cystic Fibrosis (CF) Subjects with Chronic Pseudomonas aeruginosa (PsA) Pulmonary Infection

Germany, Ireland, France, Czechia, Italy, Netherlands +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

ENCORE - A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium avium Complex (MAC)

Denmark, Spain, Hungary, Austria, Belgium, Germany +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Lung Infection trials by city

Lung Infection in Toronto Lung Infection in Vancouver Lung Infection in Montreal Lung Infection in Calgary Lung Infection in Edmonton Lung Infection in Ottawa Lung Infection in Winnipeg Lung Infection in Quebec City Lung Infection in Hamilton Lung Infection in Kitchener Lung Infection in London Lung Infection in Halifax Lung Infection in New York Lung Infection in Los Angeles Lung Infection in Chicago Lung Infection in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease